The strength of this study lies in its pioneering discovery of a positive correlation between ApoB/ApoA-I levels and the risk of recurrence of first ischemic stroke, a correlation that is particularly significant in LAA stroke patients. This evidence concerns the gene APOB and ischemic stroke.